Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q3 2025 Earnings Call Transcript October 30, 2025
Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.17, expectations were $0.13.
Operator: Good morning and welcome to the Amneal Pharmaceuticals Third Quarter 2025 Earnings Call. I will now turn the call over to Amneal’s Head of Investor Relations, Tony DiMeo. Please go ahead.
Anthony DiMeo: Good morning, and thank you for joining Amneal Pharmaceuticals’ third quarter 2025...
